Status:
COMPLETED
Efficacy of Combined Adductor and Tibial Nerve Blocks for Pain Management in Knee Arthroplasty
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Postoperative Pain Management
Total Knee Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to explore methods for enhancing pain relief following knee replacement surgery, a prevalent procedure for individuals with severe knee arthritis. Effective postoperative pain manageme...
Detailed Description
Total knee arthroplasty (TKA), or knee replacement surgery, is a highly effective treatment for severe knee arthritis, providing significant pain relief and improved joint function. However, managing ...
Eligibility Criteria
Inclusion
- Age: 18 to 80 years. ASA Classification: Patients classified as ASA I, II, or III. Surgical Procedure: Scheduled for primary unilateral total knee arthroplasty (TKA) under combined spinal-epidural anesthesia.
- Informed Consent: Ability to understand and provide written informed consent for participation in the study.
Exclusion
- ASA Classification: Patients classified as ASA IV or V. Surgical History: Revision TKA or any previous knee surgeries on the affected joint.
- Medical Conditions:
- Infection or neuropathy at the injection site. Coagulopathy or use of anticoagulant medications. Severe cardiac, hepatic, respiratory, or renal disease. Diagnosis of diabetic neuropathy. History of cerebrovascular accident with motor or sensory deficits. Neuropsychiatric disorders that affect cognition or communication.
- Pain Management:
- Inability to understand or use the Visual Analog Scale (VAS) for pain assessment.
- Long-term use of analgesic therapy that could interfere with study assessments. Allergies: Known allergy to local anesthetics used in the study. Block Failure: Failed blocks or anesthesia issues prior to surgery.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06552897
Start Date
May 1 2022
End Date
December 31 2022
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences University Ankara City Hospital
Etimesgut, Ankara, Turkey (Türkiye), 06790